0.42 / 0.74%
Real-time price in USDToday's changeShares traded1 year changeBeta
As of Mar 27 2015 19:09 GMT. BATS BZX Real-Time Last Sale


As of last trade, AbbVie Inc (ABBV:NYQ) traded at 57.70, 26.80% above the 52 week low of 45.50 set on Apr 11, 2014.

52-week range
Apr 11 2014
Dec 08 2014
Markit short selling activity
Day high58.05
Day low57.31
Previous close57.27
Average volume11.20m
Shares outstanding1.59bn
Free float1.57bn
P/E (TTM)52.14
Market cap91.18bn USD
Annual div (IAD)2.04 USD
Annual div yield (IAD)3.56%
Div ex-dateJan 13 2015
Div pay-dateFeb 13 2015
Next div ex-dateApr 13 2015
Next div pay-dateMay 15 2015
As of Mar 27 2015 19:09 GMT.BATS BZX Real-Time Quote
Last IC View
The last IC recommendation on AbbVie Inc shares was Hold at 4,801 on 16 Jul 2014
Read the full article

Comparative analysis

Past 90 days
1 week1 month6 months1 year5 years
AbbVie Inc-4.62 %-4.78 %-2.67 %+11.52 %0.00%
S&P 500 INDEX-2.46 %-2.30 %+3.70 %+11.20 %+76.25 %
USA/HEALTH CARE+4.35 %+4.09 %+14.56 %+22.80 %+57.51 %
USA/PHARMACEUTICALS+3.35 %+3.16 %+10.01 %+16.27 %+50.74 %
Data delayed at least 15 minutes, as of Mar 27 2015 18:53 GMT.
© Thomson Reuters Click for restrictions.

Real-time data provided by BATS.

All markets data located on is subject to the FT Terms & Conditions.

All content on is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.

Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.